Tai-an Lin

CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression

Yanxia Guo, Alice M. Walsh, Ursula Fearon et al. · The Journal of Immunology · 2017 · 118 citations

Life Sciences, Immunology, Pathobiology +15

Preclinical Characterization of Linrodostat Mesylate, a Novel, Potent, and Selective Oral Indoleamine 2,3-Dioxygenase 1 Inhibitor

Aaron Balog, Tai-an Lin, Derrick Maley et al. · Molecular Cancer Therapeutics · 2020 · 61 citations · Full text

Medicine, Immunology, Pharmacology +16

RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response

Xuefeng Yin, Leopoldo Luistro, Hua Zhong et al. · Clinical Cancer Research · 2013 · 48 citations · Full text

Medicine, Immunology, Pharmacology +17

Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 1

Emily C. Cherney, Liping Zhang, Susheel J. Nara et al. · ACS Medicinal Chemistry Letters · 2021 · 27 citations · Full text

Medicine, Oncology, Pharmacology +13

Current and emerging therapies for Achondroplasia: The dawn of precision medicine

Étienne Dardenne, Noboru Ishiyama, Tai-an Lin et al. · Bioorganic & Medicinal Chemistry · 2023 · 14 citations

Medicine, Molecular Medicine, Precision Medicine +4